Question 1

Am I eligible for this trial based on my current eye condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. clinical trial (NCT01908816). Contact the study team or your healthcare provider for specific answers.

Question 2

How does ranibizumab compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. clinical trial (NCT01908816). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of ranibizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. clinical trial (NCT01908816). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatment if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. clinical trial (NCT01908816). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my condition does not improve with this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. clinical trial (NCT01908816). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks I should be aware of before starting this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. clinical trial (NCT01908816). Contact the study team or your healthcare provider for specific answers.

What this study is about